Modulation of multiple sclerosis by sunlight exposure: role of cis-urocanic acid

J Neuroimmunol. 2013 Aug 15;261(1-2):134-40. doi: 10.1016/j.jneuroim.2013.05.014. Epub 2013 Jun 22.

Abstract

The role of cis-urocanic acid (UCA) as a UV-mediated immunomodulator in MS patients was investigated. Plasma levels of cis-UCA were significantly lower in MS patients compared to controls. Stimulation of MBP- and MOG-specific T cells in the presence of cis-UCA, significantly increased IL-10, and inhibited IFN-γ production. PBMCs cultured in the presence of cis-UCA increased CD4(+)CD25(+)FoxP3(+) regulatory T cell percentages. Dendritic cells cultured in the presence of cis-UCA significantly reduced Ag presentation capacity. Finally, cis-UCA activated the 5-HT2A receptor, inducing the increase in phosphorylated forms of ERK 1/2 and JNK2. Thus, in addition to vitamin D, cis-UCA also appears to be an additional UV-mediated immunomodulator.

Keywords: Cytokines; Environmental factors; Multiple sclerosis; Ultraviolet radiation; Urocanic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Brazil / epidemiology
  • Female
  • Humans
  • Immunologic Factors / blood
  • Immunologic Factors / physiology*
  • Male
  • Middle Aged
  • Multiple Sclerosis / blood*
  • Multiple Sclerosis / epidemiology
  • Multiple Sclerosis / immunology
  • Sunlight*
  • Urocanic Acid / blood
  • Urocanic Acid / pharmacology*

Substances

  • Biomarkers
  • Immunologic Factors
  • Urocanic Acid